Basal activity profiles of NPH and [N(ε)-palmitoyl Lys (B29)] human insulins in subjects with IDDM

Diabetologia

Volumn 41, Issue 1, 1998, Pages 116-120

  Radziuk, J ^a   Pye, S ^a   Bradley, B ^a   Braaten, J ^a   Vignati, L ^b   Roach, P ^b   Bowsher, R ^b   DiMarchi, R ^b   Chance, R ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Acylated insulin; Glucose turnover; Insulin; Insulin therapy; NPH; Pharmacokinetics

Indexed keywords

3 HYDROXYBUTYRIC ACID; C PEPTIDE; FATTY ACID; GLUCOSE; INSULIN[N PALMITOYL B29 LYSINE]; ISOPHANE INSULIN; LACTIC ACID; RECOMBINANT HUMAN INSULIN; UNCLASSIFIED DRUG;

ACYLATION; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG PROTEIN BINDING; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; GLUCOSE METABOLISM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031930095     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050876     Document Type: Article

References (10)

1. The DCCT Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986
2. Brange J, Owens DR, Kang S, Vølund A (1990) Monomeric insulins and their experimental and clinical implications. Diabetes Care 13: 923-954
3. DiMarchi RD, Mayer JP, Fan L et al. (1992) Synthesis of a fast-acting insulin based on structural homology with insulin-like growth factor I. In: Smith JA, Rivier JE (eds) Peptides: chemistry and biology, Proceedings of the twelfth American peptide symposium. Leiden ESCOM, pp 26-28
4. B29-human insulin assessed in a conscious pig model. Diabetes 46: 548-556
5. Galloway JA, Spradlin CT, Nelson RL, Wentworth SM, Davidson JA, Swarner JL (1981) Factors influencing the absorption, serum insulin concentration, and blood glucose responses after injections of regular insulin and various insulin mixtures. Diabetes Care 4: 366-376
6. Lauritzen T (1985) Pharmacokinetics of subcutaneously administered insulin and its clinical implications. Acta Endocrinol 110[Suppl 272]:45-48
7. Markussen J, Havelund S, Kurtzhals P et al. (1996) Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigs. Diabetologia 39: 281-288
8. Myers SR, Yakubu-Madus FE, Johnson WT et al. (1997) Acylation of human insulin with palmitic acid extends the time action of human insulin in diabetic dogs. Diabetes 46: 637-642
9. Mokan M, Gerich JE (1992) A simple insulin infusion algorithm for establishing and maintaining overnight near-normoglycaemia in type I and type II diabetes. J Clin Endocrinol Metab 74: 943-945
10. Radziuk J, Davies J, Pye S, McDonald TJ (1994) Differential effects of a graded selective suppression of insulin secretion with galanin on glucose production and removal in dogs. Pancreas 9: 485-493